aTyr Pharma Ownership 2024 | Who Owns aTyr Pharma Now?
Institutional Ownership
51.34%
Insider Ownership
2.62%
Retail Ownership
46.04%
Institutional Holders
22.00
aTyr Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 22.20% | 0.05% | 14,666,600 | 4,497,000 | 44.22% | 22,879,896,000 | Jun 30, 2024 |
| FMR LLC | 15.67% | 0.00% | 10,351,641 | 1,428,431 | 16.01% | 16,148,560 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 4.54% | 0.38% | 3,000,000 | -100,000 | -3.23% | 4,680,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.01% | 0.00% | 2,652,157 | - | - | 4,137,365 | Jun 30, 2024 |
| TIKVAH MANAGEMENT LLC | 3.72% | 1.25% | 2,460,833 | - | - | 3,838,899 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 2.95% | 1.83% | 1,946,477 | 500,000 | 34.57% | 3,036,504 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 2.83% | 0.02% | 1,867,633 | 362,078 | 24.05% | 2,913,507 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.55% | 0.03% | 1,683,162 | 1,883 | 0.11% | 2,625,733 | Jun 30, 2024 |
| BLACKROCK INC. | 2.11% | - | 1,392,074 | 27,194 | 1.99% | 2,171,636 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.96% | 0.00% | 1,293,814 | 20,959 | 1.65% | 2,018,350 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.51% | 0.00% | 1,000,000 | 1,000,000 | 100.00% | 1,560,000 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.21% | 0.39% | 800,000 | 200,000 | 33.33% | 1,248,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.02% | 0.11% | 671,134 | 200,000 | 42.45% | 1,046,969 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 662,684 | 67,573 | 11.35% | 1,034,003 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.49% | 0.04% | 322,460 | 98,313 | 43.86% | 503,000 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.47% | 0.62% | 313,028 | 313,028 | 100.00% | 488,324 | Jun 30, 2024 |
| STATE STREET CORP | 0.25% | - | 168,308 | 1,500 | 0.90% | 262,560,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.22% | 0.00% | 145,524 | -51,220 | -26.03% | 227,017 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.18% | - | 118,456 | 19,290 | 19.45% | 184,791,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.18% | - | 117,037 | -39,138 | -25.06% | 182,578 | Jun 30, 2024 |
aTyr Pharma's largest institutional shareholder is FEDERATED HERMES, INC., holding 22.20% of the company's total share outstanding, currently valued at $22.88B. The top 10 institutional shareholders own together 62.52% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CHECKPOINT CAPITAL L.P. | 2.95% | 1.83% | 1,946,477 | 500,000 | 34.57% | 3,036,504 | Jun 30, 2024 |
| TIKVAH MANAGEMENT LLC | 3.72% | 1.25% | 2,460,833 | - | - | 3,838,899 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.47% | 0.62% | 313,028 | 313,028 | 100.00% | 488,324 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.21% | 0.39% | 800,000 | 200,000 | 33.33% | 1,248,000 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 4.54% | 0.38% | 3,000,000 | -100,000 | -3.23% | 4,680,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.02% | 0.11% | 671,134 | 200,000 | 42.45% | 1,046,969 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 22.20% | 0.05% | 14,666,600 | 4,497,000 | 44.22% | 22,879,896,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.49% | 0.04% | 322,460 | 98,313 | 43.86% | 503,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 2.55% | 0.03% | 1,683,162 | 1,883 | 0.11% | 2,625,733 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 2.83% | 0.02% | 1,867,633 | 362,078 | 24.05% | 2,913,507 | Jun 30, 2024 |
| ALTERNA WEALTH MANAGEMENT, INC | 0.02% | 0.01% | 10,000 | - | - | 15,600 | Jun 30, 2024 |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.10% | 0.01% | 67,725 | 33,250 | 96.45% | 105,651 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.96% | 0.00% | 1,293,814 | 20,959 | 1.65% | 2,018,350 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 27,966 | 27,966 | 100.00% | 44,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.51% | 0.00% | 1,000,000 | 1,000,000 | 100.00% | 1,560,000 | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | 0.05% | 0.00% | 30,423 | 100 | 0.33% | 47,460 | Jun 30, 2024 |
| FMR LLC | 15.67% | 0.00% | 10,351,641 | 1,428,431 | 16.01% | 16,148,560 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 27,338 | 21,071 | 336.22% | 42,647 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.06% | 0.00% | 38,900 | 18,400 | 89.76% | 60,684 | Jun 30, 2024 |
| D.A. DAVIDSON & CO. | 0.04% | 0.00% | 27,850 | 1,500 | 5.69% | 43,446,000 | Jun 30, 2024 |
The largest aTyr Pharma shareholder by % of total assets is CHECKPOINT CAPITAL L.P.. The company owns 1.95M shares of aTyr Pharma (LIFE), representing 1.83% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 22.20% | 0.05% | 14,666,600 | 4,497,000 | 44.22% | 22,879,896,000 | Jun 30, 2024 |
| FMR LLC | 15.67% | 0.00% | 10,351,641 | 1,428,431 | 16.01% | 16,148,560 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.51% | 0.00% | 1,000,000 | 1,000,000 | 100.00% | 1,560,000 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 2.95% | 1.83% | 1,946,477 | 500,000 | 34.57% | 3,036,504 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 2.83% | 0.02% | 1,867,633 | 362,078 | 24.05% | 2,913,507 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.47% | 0.62% | 313,028 | 313,028 | 100.00% | 488,324 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.02% | 0.11% | 671,134 | 200,000 | 42.45% | 1,046,969 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.21% | 0.39% | 800,000 | 200,000 | 33.33% | 1,248,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.49% | 0.04% | 322,460 | 98,313 | 43.86% | 503,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 662,684 | 67,573 | 11.35% | 1,034,003 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.16% | 0.00% | 106,432 | 43,951 | 70.34% | 166,034 | Jun 30, 2024 |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 0.10% | 0.01% | 67,725 | 33,250 | 96.45% | 105,651 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 27,966 | 27,966 | 100.00% | 44,000 | Jun 30, 2024 |
| BLACKROCK INC. | 2.11% | - | 1,392,074 | 27,194 | 1.99% | 2,171,636 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 27,338 | 21,071 | 336.22% | 42,647 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.96% | 0.00% | 1,293,814 | 20,959 | 1.65% | 2,018,350 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.18% | - | 118,456 | 19,290 | 19.45% | 184,791,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.06% | 0.00% | 38,900 | 18,400 | 89.76% | 60,684 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | 0.00% | 12,675 | 12,675 | 100.00% | 19,773 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.09% | 0.00% | 60,487 | 6,444 | 11.92% | 94,360 | Jun 30, 2024 |
As of Jun 30 2024, aTyr Pharma's largest institutional buyer is FEDERATED HERMES, INC.. The company purchased 4.50M stocks of LIFE, valued at $22.88B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -604,299 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -217,233 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -158,619 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 4.54% | 0.38% | 3,000,000 | -100,000 | -3.23% | 4,680,000 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | - | - | - | -91,232 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -83,328 | -100.00% | - | Jun 30, 2024 |
| KINGSWOOD WEALTH ADVISORS, LLC | - | - | - | -60,000 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.22% | 0.00% | 145,524 | -51,220 | -26.03% | 227,017 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -49,904 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -45,366 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -43,892 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.18% | - | 117,037 | -39,138 | -25.06% | 182,578 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -28,256 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -20,192 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | 1 | -19,717 | -99.99% | 2 | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -17,600 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -17,487 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -16,000 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 20,686 | -13,168 | -38.90% | 32,270 | Jun 30, 2024 |
As of Jun 30 2024, aTyr Pharma's biggest institutional seller is OCTAGON CAPITAL ADVISORS LP. The company sold -0.70M shares of LIFE, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.51% | 0.00% | 1,000,000 | 1,000,000 | 100.00% | 1,560,000 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.47% | 0.62% | 313,028 | 313,028 | 100.00% | 488,324 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | 0.00% | 12,675 | 12,675 | 100.00% | 19,773 | Jun 30, 2024 |
| SACHETTA, LLC | 0.00% | 0.00% | 150 | 150 | 100.00% | 297 | Jun 30, 2024 |
aTyr Pharma's largest new institutional shareholder by number of shares is ADAGE CAPITAL PARTNERS GP, L.L.C., purchased 1.00M shares, valued at $1.56M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -604,299 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -217,233 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -158,619 | -100.00% | - | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | - | - | - | -91,232 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -83,328 | -100.00% | - | Jun 30, 2024 |
| KINGSWOOD WEALTH ADVISORS, LLC | - | - | - | -60,000 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -49,904 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -45,366 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -43,892 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -28,256 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -20,192 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -17,600 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -17,487 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -16,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -10,088 | -100.00% | - | Jun 30, 2024 |
aTyr Pharma's largest sold out institutional shareholder by shares sold is OCTAGON CAPITAL ADVISORS LP, sold -0.70M shares, valued at -, as of undefined.
aTyr Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BNY Mellon U.S. Mortgage Fund, Inc. | 0.80% | 2,575,000 | - | - | Apr 30, 2022 |
| Federated Hermes Equity Funds | 0.52% | 10,049,000 | - | - | Jan 31, 2024 |
| BNY Mellon Investment Funds VII, Inc. | 0.43% | 491,485 | -8,514 | -1.70% | Apr 30, 2022 |
| MORGAN STANLEY U.S. GOVERNMENT SECURITIES TRUST | 0.34% | 1,375,000 | - | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.29% | 12,590,000 | - | - | Dec 31, 2023 |
| JANUS ASPEN SERIES | 0.27% | 11,845,774 | - | - | Dec 31, 2023 |
| BBH Trust | 0.25% | 23,600,000 | - | - | Jan 31, 2024 |
| Guggenheim Strategy Funds Trust | 0.20% | 2,015,088 | - | - | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.15% | 46,192,000 | - | - | Dec 31, 2023 |
| JOHN HANCOCK INCOME SECURITIES TRUST | 0.15% | 484,000 | - | - | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.13% | 41,361,417 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.12% | 3,499,791 | -73,984 | -2.07% | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.12% | 7,460,000 | - | - | Feb 29, 2024 |
| Fidelity Central Investment Portfolios II LLC | 0.12% | 57,498,000 | - | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.12% | 5,233,333 | - | - | Dec 31, 2023 |
| JOHN HANCOCK SOVEREIGN BOND FUND | 0.11% | 33,864,000 | - | - | Feb 29, 2024 |
| Voya INTERMEDIATE BOND PORTFOLIO | 0.11% | 5,000,000 | - | - | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.10% | 2,930,234 | - | - | Dec 31, 2023 |
| Guardian Variable Products Trust | 0.09% | 1,474,455 | - | - | Mar 31, 2024 |
| FIDELITY INCOME FUND /MA/ | 0.08% | 44,148,000 | - | - | Feb 29, 2024 |
| AIM INVESTMENT SECURITIES FUNDS (INVESCO INVESTMENT SECURITIES FUNDS) | 0.08% | 7,254,319 | - | - | Feb 29, 2024 |
| FIDELITY GARRISON STREET TRUST | 0.08% | 3,430,000 | - | - | Mar 31, 2024 |
| INVESCO ACTIVELY MANAGED EXCHANGE-TRADED FUND TRUST | 0.08% | 3,440,395 | 1,641,560 | 91.26% | Jan 31, 2024 |
| Fidelity Merrimack Street Trust | 0.08% | 7,860,000 | - | - | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.08% | 23,586,369 | - | - | Dec 31, 2023 |
| GPS Funds I | 0.08% | 407,932 | -113,041 | -21.70% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 38,420 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios II LLC | 0.07% | 33,561,000 | - | - | Mar 31, 2024 |
| Variable Insurance Products Fund V | 0.07% | 8,679,003 | - | - | Mar 31, 2024 |
| JOHN HANCOCK SOVEREIGN BOND FUND | 0.07% | 19,530,633 | - | - | Feb 29, 2024 |
| AIM INVESTMENT SECURITIES FUNDS (INVESCO INVESTMENT SECURITIES FUNDS) | 0.06% | 5,701,226 | - | - | Feb 29, 2024 |
| JOHN HANCOCK INCOME SECURITIES TRUST | 0.06% | 216,253 | - | - | Jan 31, 2024 |
| JOHN HANCOCK BOND TRUST | 0.06% | 4,271,000 | - | - | Feb 29, 2024 |
| LORD ABBETT GLOBAL FUND INC | 0.06% | 100,000 | - | - | Mar 31, 2024 |
| FIDELITY GARRISON STREET TRUST | 0.06% | 2,383,000 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.06% | 17,693,463 | - | - | Dec 31, 2023 |
| Hartford Funds Exchange-Traded Trust | 0.06% | 3,263,460 | - | - | Jan 31, 2024 |
| VANGUARD WELLESLEY INCOME FUND | 0.06% | 19,433,319 | - | - | Mar 31, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.05% | 52,370,000 | - | - | Feb 29, 2024 |
| FIDELITY GARRISON STREET TRUST | 0.05% | 2,199,143 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.05% | 3,179,908 | - | - | Feb 29, 2024 |
| FIDELITY INCOME FUND /MA/ | 0.05% | 26,395,000 | - | - | Feb 29, 2024 |
| Fidelity Central Investment Portfolios II LLC | 0.05% | 23,546,066 | - | - | Mar 31, 2024 |
| Catholic Responsible Investments Funds | 0.05% | 1,867,643 | - | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.05% | 59,110,997 | - | - | Feb 29, 2024 |
| FIDELITY INCOME FUND /MA/ | 0.05% | 24,584,083 | - | - | Feb 29, 2024 |
| Voya FUNDS TRUST | 0.04% | 12,000,000 | - | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.04% | 1,854,000 | - | - | Dec 31, 2023 |
| Fidelity Central Investment Portfolios II LLC | 0.04% | 19,262,000 | - | - | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.04% | 3,345,000 | - | - | Mar 31, 2024 |
| Variable Insurance Products Fund V | 0.04% | 4,964,000 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 2,258,063 | - | - | Feb 29, 2024 |
| LORD ABBETT BOND DEBENTURE FUND INC | 0.03% | 37,340,000 | - | - | Mar 31, 2024 |
| JOHN HANCOCK INCOME SECURITIES TRUST | 0.03% | 114,024 | - | - | Jan 31, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.03% | 32,536,311 | - | - | Feb 29, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.03% | 10,650,000 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.03% | 201,508 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.03% | 1,784,090 | - | - | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.03% | 10,000,000 | - | - | Dec 31, 2023 |
| FIDELITY GARRISON STREET TRUST | 0.03% | 1,335,000 | - | - | Mar 31, 2024 |
| JOHN HANCOCK BOND TRUST | 0.03% | 2,127,147 | - | - | Feb 29, 2024 |
| LORD ABBETT SERIES FUND INC | 0.03% | 1,980,000 | - | - | Mar 31, 2024 |
| LORD ABBETT SERIES FUND INC | 0.03% | 1,965,940 | - | - | Mar 31, 2024 |
| JOHN HANCOCK BOND TRUST | 0.03% | 1,975,770 | - | - | Feb 29, 2024 |
| Variable Insurance Products Fund V | 0.03% | 3,728,166 | - | - | Mar 31, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.03% | 6,679,282 | - | - | Feb 29, 2024 |
| FIDELITY INCOME FUND /MA/ | 0.03% | 14,790,000 | - | - | Feb 29, 2024 |
| ANCHOR SERIES TRUST | 0.03% | 895,000 | - | - | Sep 30, 2021 |
| FIDELITY ADVISOR SERIES II | 0.03% | 3,997,739 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.03% | 110,000,000 | - | - | Feb 29, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.03% | 120,600 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.03% | 1,619,934 | - | 0.00% | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.02% | 29,353,000 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY INVESTMENT TRUST | 0.02% | 3,337,183 | 275,231 | 8.99% | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.02% | 7,214,000 | - | - | Dec 31, 2023 |
| Forethought Variable Insurance Trust | 0.02% | 98,297 | - | - | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.02% | 5,250,000 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.02% | 9,146,537 | - | - | Feb 29, 2024 |
| Variable Insurance Products Fund V | 0.02% | 2,823,000 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.02% | 688,079 | - | - | Mar 31, 2024 |
| LORD ABBETT BOND DEBENTURE FUND INC | 0.02% | 22,510,016 | - | - | Mar 31, 2024 |
| DOMINI INVESTMENT TRUST | 0.02% | 117,956 | - | - | Jan 31, 2024 |
| Fidelity Merrimack Street Trust | 0.02% | 1,986,000 | - | - | Feb 29, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.02% | 800,000 | - | - | Mar 31, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.02% | 4,546,236 | - | - | Feb 29, 2024 |
| Catholic Responsible Investments Funds | 0.02% | 737,227 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.02% | 4,423,365 | - | - | Jan 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.02% | 1,543,263 | - | - | Mar 31, 2024 |
| Fidelity Merrimack Street Trust | 0.02% | 1,774,261 | - | - | Feb 29, 2024 |
| JOHN HANCOCK SOVEREIGN BOND FUND | 0.02% | 5,042,636 | - | - | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.02% | 2,072,101 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.02% | 65,580,432 | - | - | Feb 29, 2024 |
| GUGGENHEIM FUNDS TRUST | 0.02% | 8,846,731 | - | - | Dec 31, 2023 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.02% | 638,930 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.02% | 62,549,000 | - | - | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.01% | 17,197,450 | - | - | Feb 29, 2024 |
| Fidelity Central Investment Portfolios II LLC | 0.01% | 6,416,829 | - | - | Mar 31, 2024 |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0.01% | 982,970 | - | - | Feb 29, 2024 |
| Fidelity Central Investment Portfolios II LLC | 0.01% | 5,605,878 | - | - | Mar 31, 2024 |
| MML Series Investment Fund II | 0.01% | 2,267,712 | - | - | Dec 31, 2023 |
aTyr Pharma's largest mutual fund holder by % of total assets is "BNY Mellon U.S. Mortgage Fund, Inc.", owning 2.58M shares, compromising 0.80% of its total assets.
aTyr Pharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 22 | -62.07% |
| 31 Mar, 24 | 58 | 20.83% |
| 31 Dec, 23 | 48 | 9.09% |
| 30 Sep, 23 | 44 | -2.22% |
| 30 Jun, 23 | 45 | 15.38% |
| 31 Mar, 23 | 39 | - |
| 31 Dec, 22 | 39 | 11.43% |
| 30 Sep, 22 | 35 | -7.89% |
| 30 Jun, 22 | 38 | -15.56% |
| 31 Mar, 22 | 45 | -11.76% |
| 31 Dec, 21 | 51 | - |
| 30 Sep, 21 | 51 | 104.00% |
| 30 Jun, 21 | 25 | 31.58% |
| 31 Mar, 21 | 19 | - |
| 31 Dec, 20 | 19 | -5.00% |
| 30 Sep, 20 | 20 | -4.76% |
| 30 Jun, 20 | 21 | - |
| 31 Mar, 20 | 21 | 50.00% |
| 31 Dec, 19 | 14 | -6.67% |
| 30 Sep, 19 | 15 | 200.00% |
| 30 Jun, 19 | 5 | - |
As of 30 Jun 24, 22 institutions are holding aTyr Pharma's shares, representing a decrease of -62.07% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 33,928,397 | -18.84% |
| 31 Mar, 24 | 41,806,011 | 1.40% |
| 31 Dec, 23 | 41,229,924 | 11.03% |
| 30 Sep, 23 | 37,134,555 | 4.11% |
| 30 Jun, 23 | 35,668,430 | 4.67% |
| 31 Mar, 23 | 34,075,897 | 85.66% |
| 31 Dec, 22 | 18,353,688 | -3.71% |
| 30 Sep, 22 | 19,060,200 | 1.56% |
| 30 Jun, 22 | 18,768,346 | -4.38% |
| 31 Mar, 22 | 19,627,641 | -4.51% |
| 31 Dec, 21 | 20,554,853 | 9.19% |
| 30 Sep, 21 | 18,824,963 | 177.34% |
| 30 Jun, 21 | 6,787,711 | 17.44% |
| 31 Mar, 21 | 5,779,531 | 0.28% |
| 31 Dec, 20 | 5,763,578 | 2.29% |
| 30 Sep, 20 | 5,634,819 | 2.97% |
| 30 Jun, 20 | 5,472,169 | 6.99% |
| 31 Mar, 20 | 5,114,483 | 185.06% |
| 31 Dec, 19 | 1,794,157 | 3.87% |
| 30 Sep, 19 | 1,727,317 | 225.68% |
| 30 Jun, 19 | 530,377 | - |
aTyr Pharma (LIFE) has 33.93M shares outstanding as of 30 Jun 24, down -18.84% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 51.34% | 0.84% |
| 31 Mar, 24 | 77.99% | 1.54% |
| 31 Dec, 23 | 71.23% | 1.57% |
| 30 Sep, 23 | 67.34% | 0.93% |
| 30 Jun, 23 | 85.13% | 1.29% |
| 31 Mar, 23 | 81.33% | 2.05% |
| 31 Dec, 22 | 63.04% | 1.43% |
| 30 Sep, 22 | 66.50% | 1.49% |
| 30 Jun, 22 | 66.88% | 1.34% |
| 31 Mar, 22 | 70.56% | 1.29% |
| 31 Dec, 21 | 73.96% | 0.69% |
| 30 Sep, 21 | 103.67% | 5.85% |
| 30 Jun, 21 | 42.09% | 2.51% |
| 31 Mar, 21 | 40.98% | 1.38% |
| 31 Dec, 20 | 54.51% | 1.60% |
| 30 Sep, 20 | 58.40% | 1.71% |
| 30 Jun, 20 | 58.48% | 1.06% |
| 31 Mar, 20 | 74.32% | 3.50% |
| 31 Dec, 19 | 46.11% | 2.29% |
| 30 Sep, 19 | 44.91% | 16.81% |
| 30 Jun, 19 | 16.34% | - |
As of 30 Jun 24, aTyr Pharma is held by 51.34% institutional shareholders, representing a 0.84% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 12 | -66.67% |
| 31 Mar, 24 | 36 | 50.00% |
| 31 Dec, 23 | 24 | 60.00% |
| 30 Sep, 23 | 15 | -50.00% |
| 30 Jun, 23 | 30 | 25.00% |
| 31 Mar, 23 | 24 | 20.00% |
| 31 Dec, 22 | 20 | 17.65% |
| 30 Sep, 22 | 17 | 30.77% |
| 30 Jun, 22 | 13 | -38.10% |
| 31 Mar, 22 | 21 | -22.22% |
| 31 Dec, 21 | 27 | -25.00% |
| 30 Sep, 21 | 36 | 125.00% |
| 30 Jun, 21 | 16 | 23.08% |
| 31 Mar, 21 | 13 | 18.18% |
| 31 Dec, 20 | 11 | - |
| 30 Sep, 20 | 11 | 10.00% |
| 30 Jun, 20 | 10 | -41.18% |
| 31 Mar, 20 | 17 | 112.50% |
| 31 Dec, 19 | 8 | -20.00% |
| 30 Sep, 19 | 10 | 100.00% |
| 30 Jun, 19 | 5 | - |
12 institutional shareholders have increased their position in LIFE stock as of 30 Jun 24 compared to 36 in the previous quarter (a -66.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 4 | -60.00% |
| 31 Mar, 24 | 10 | - |
| 31 Dec, 23 | 10 | -44.44% |
| 30 Sep, 23 | 18 | 157.14% |
| 30 Jun, 23 | 7 | - |
| 31 Mar, 23 | 7 | -12.50% |
| 31 Dec, 22 | 8 | 60.00% |
| 30 Sep, 22 | 5 | -54.55% |
| 30 Jun, 22 | 11 | 10.00% |
| 31 Mar, 22 | 10 | -23.08% |
| 31 Dec, 21 | 13 | 160.00% |
| 30 Sep, 21 | 5 | 25.00% |
| 30 Jun, 21 | 4 | - |
| 31 Mar, 21 | 4 | - |
| 31 Dec, 20 | 4 | 100.00% |
| 30 Sep, 20 | 2 | -50.00% |
| 30 Jun, 20 | 4 | - |
| 31 Mar, 20 | - | -100.00% |
| 31 Dec, 19 | 3 | -40.00% |
| 30 Sep, 19 | 5 | - |
| 30 Jun, 19 | - | - |
4 institutional shareholders have reduced their position in LIFE stock as of 30 Jun 24 compared to 10 in the previous quarter (a -60.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 22 | -62.07% | 33,928,397 | -18.84% | 51.34% | 0.84% | 12 | -66.67% | 4 | -60.00% |
| 31 Mar, 24 | 58 | 20.83% | 41,806,011 | 1.40% | 77.99% | 1.54% | 36 | 50.00% | 10 | - |
| 31 Dec, 23 | 48 | 9.09% | 41,229,924 | 11.03% | 71.23% | 1.57% | 24 | 60.00% | 10 | -44.44% |
| 30 Sep, 23 | 44 | -2.22% | 37,134,555 | 4.11% | 67.34% | 0.93% | 15 | -50.00% | 18 | 157.14% |
| 30 Jun, 23 | 45 | 15.38% | 35,668,430 | 4.67% | 85.13% | 1.29% | 30 | 25.00% | 7 | - |
| 31 Mar, 23 | 39 | - | 34,075,897 | 85.66% | 81.33% | 2.05% | 24 | 20.00% | 7 | -12.50% |
| 31 Dec, 22 | 39 | 11.43% | 18,353,688 | -3.71% | 63.04% | 1.43% | 20 | 17.65% | 8 | 60.00% |
| 30 Sep, 22 | 35 | -7.89% | 19,060,200 | 1.56% | 66.50% | 1.49% | 17 | 30.77% | 5 | -54.55% |
| 30 Jun, 22 | 38 | -15.56% | 18,768,346 | -4.38% | 66.88% | 1.34% | 13 | -38.10% | 11 | 10.00% |
| 31 Mar, 22 | 45 | -11.76% | 19,627,641 | -4.51% | 70.56% | 1.29% | 21 | -22.22% | 10 | -23.08% |
| 31 Dec, 21 | 51 | - | 20,554,853 | 9.19% | 73.96% | 0.69% | 27 | -25.00% | 13 | 160.00% |
| 30 Sep, 21 | 51 | 104.00% | 18,824,963 | 177.34% | 103.67% | 5.85% | 36 | 125.00% | 5 | 25.00% |
| 30 Jun, 21 | 25 | 31.58% | 6,787,711 | 17.44% | 42.09% | 2.51% | 16 | 23.08% | 4 | - |
| 31 Mar, 21 | 19 | - | 5,779,531 | 0.28% | 40.98% | 1.38% | 13 | 18.18% | 4 | - |
| 31 Dec, 20 | 19 | -5.00% | 5,763,578 | 2.29% | 54.51% | 1.60% | 11 | - | 4 | 100.00% |
| 30 Sep, 20 | 20 | -4.76% | 5,634,819 | 2.97% | 58.40% | 1.71% | 11 | 10.00% | 2 | -50.00% |
| 30 Jun, 20 | 21 | - | 5,472,169 | 6.99% | 58.48% | 1.06% | 10 | -41.18% | 4 | - |
| 31 Mar, 20 | 21 | 50.00% | 5,114,483 | 185.06% | 74.32% | 3.50% | 17 | 112.50% | - | -100.00% |
| 31 Dec, 19 | 14 | -6.67% | 1,794,157 | 3.87% | 46.11% | 2.29% | 8 | -20.00% | 3 | -40.00% |
| 30 Sep, 19 | 15 | 200.00% | 1,727,317 | 225.68% | 44.91% | 16.81% | 10 | 100.00% | 5 | - |
| 30 Jun, 19 | 5 | - | 530,377 | - | 16.34% | - | 5 | - | - | - |
aTyr Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of aTyr Pharma's stock was made by Shukla Sanjay on Feb 06 2024, selling 10,375 shares at - per share (valued at -). The last insider buy of LIFE was made by COUGHLIN TIMOTHY on Jun 03 2024, buying 50,000 shares at $1.75 per share (worth $87.50K).
aTyr Pharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 6 | - | - |
| Q1 2024 | 6 | 4 | 150.00% |
| Q4 2023 | 4 | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 14 | 7 | 200.00% |
| Q1 2023 | 6 | 4 | 150.00% |
| Q4 2022 | 1 | - | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 9 | - | - |
| Q1 2022 | 8 | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 2 | 1 | 200.00% |
| Q2 2021 | 11 | 1 | 1100.00% |
| Q1 2021 | 6 | 4 | 150.00% |
| Q3 2020 | - | 4 | - |
| Q2 2020 | 13 | 3 | 433.33% |
| Q1 2020 | 6 | 4 | 150.00% |
| Q2 2019 | 10 | 2 | 500.00% |
| Q1 2019 | 5 | 10 | 50.00% |
| Q4 2018 | 3 | - | - |
6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by aTyr Pharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | 4 | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | 1 | - |
| Q4 2022 | 1 | - | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 2 | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 2 | 1 | 200.00% |
| Q1 2021 | - | 2 | - |
| Q3 2020 | - | 4 | - |
| Q2 2020 | 2 | 2 | 100.00% |
| Q1 2020 | 1 | 2 | 50.00% |
| Q2 2019 | - | 1 | - |
| Q1 2019 | - | - | - |
| Q4 2018 | 3 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of aTyr Pharma's stocks.
aTyr Pharma Peer Ownership
LIFE Ownership FAQ
Who Owns aTyr Pharma?
aTyr Pharma is owned by institutional shareholders (51.34%), insiders (2.62%), and public (46.04%). The largest institutional shareholder of aTyr Pharma is FEDERATED HERMES, INC. (22.20% of total shares) and the top mutual fund owner is BNY Mellon U.S. Mortgage Fund, Inc. (0.80% of total shares).
Who are the major institutional shareholders of aTyr Pharma?
aTyr Pharma's major institutional shareholders are FEDERATED HERMES, INC., FMR LLC, LOGOS GLOBAL MANAGEMENT LP, VANGUARD GROUP INC, and TIKVAH MANAGEMENT LLC. The top five shareholders own together 50.14% of the company's share outstanding.
How many aTyr Pharma shareholders are there?
As of Jun 2024, there are 22 institutional shareholders of aTyr Pharma.
What percentage of aTyr Pharma is owned by FEDERATED HERMES, INC?
FEDERATED HERMES, INC owns 14.67M shares of aTyr Pharma, representing 22.20% of the company's total shares outstanding, valued at $22.88B (as of Jun 2024).
What percentage of aTyr Pharma is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 10.35M shares of aTyr Pharma (LIFE), compromising 15.67% of the company, valued at $16.15M.
What percentage of aTyr Pharma is owned by LOGOS GLOBAL MANAGEMENT LP?
LOGOS GLOBAL MANAGEMENT LP is the third largest holder of aTyr Pharma. The company owns 3M of the company's shares outstanding (worth $4.68M).